FDA approves new multiple myeloma drug despite toxicity concerns - STAT

FDA approves new multiple myeloma drug despite toxicity concerns - STAT

FDA approves new multiple myeloma drug despite toxicity concerns

By ADAM FEUERSTEIN

ANDREW HARNIK/AP

The new multiple myeloma drug, called selinexor, will be marketed by Karyopharm Therapeutics under the brand name Xpovio.

READ MORE